← Open Payments lookup

ABIGAIL GUZMAN: Open Payments

NPI 1962127795 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,796 in 145 payments from 13 companies in 2025. Trend: 2023 $1,287 · 2024 $2,428 · 2025 $2,796

Food & beverage: $2,796
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.37$875
Otsuka America Pharmaceutical, Inc.23$447
ABBVIE INC.17$319
Vanda Pharmaceuticals Inc.12$290
Alkermes, Inc.16$207
Teva Pharmaceuticals USA, Inc.11$189
E.R. Squibb & Sons, L.L.C.12$155
Janssen Pharmaceuticals, Inc8$135
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$92
Lundbeck LLC2$37

Products named: INGREZZA, REXULTI, VRAYLAR, ARISTADA, FANAPT, COBENFY, HETLIOZ, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.